A multi-billion dollar swap between Sanofi and Boehringer Ingelheim has been finalised, giving companies critical mass in the consumer healthcare and animal health markets respectively.

It’s important to maintain a temperature of 77 degrees or cooler, and above freezing, so efficacy is highest when the product ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking ... along with the integration of a new animal health business bought from Sanofi ...

The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

Boehringer Ingelheim’s innovation unit head Paola Casarosa said: “Our goal is to create more health for humans and animals. Especially in the field of oncology, there is still a massive unmet ...

Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...

Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...

Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...